Search

Objective. The purpose of this study was to evaluate the effects of physical therapy on pulmonary function and respiratory muscle strength in children with cerebral palsy (CP). Methods. A search of 10 databases was conducted for this systematic review. Initially, there were no language, study design, or time frame restrictions. All studies assessing the effect of physical therapy on the respiratory system in children with CP were included. Two reviewers independently extracted and documented data. The data extracted included description of the intervention (duration, therapeutic method) and study results (change of spirometric parameters, respiratory muscle strength). The effects of physical therapist treatment were calculated using software. Results. A total of 269 children aged 5 to 18 years from 10 studies were included. The included studies consisted of 5 different therapeutic methods (inspiratory muscle training [IMT], aerobic training, swimming, respiratory exercise, exercise with elastic bands). Physical therapist intervention led to a significant increase in the maximal expiratory pressure (MEP) (I (2) = 0%), peak expiratory flow (I (2) = 0%), and maximum oxygen consumption (I (2) = 37%). A separate analysis of the most frequently used therapy (IMT) showed a positive effect on MEP (I (2) = 0%) and maximal inspiratory pressure (I (2) = 35%). Conclusion. Various forms of physical therapy have potential to demonstrate a positive effect on maximal inspiratory pressure, MEP, and peak expiratory flow in children with CP. There is no possibility to recommend the best method and duration of the physical therapy; however, it can be suggested that physical therapy should be applied for at least 4 weeks and include IMT. Impact. CP is one of the most common causes of physical disabilities in children, and pulmonary dysfunction is the leading cause of death in people with CP. Thus, it is warranted to seek different approaches that may improve pulmonary function in people with CP. This review has shown that various forms of physical therapy have potential to improve the pulmonary function of children with CP. Keywords: Cerebral Palsy, Neuromuscular Diseases, Pulmonary Rehabilitation, Respiratory System, Spirometry, Introduction Cerebral palsy (CP) is one of the most common physical disabilities in children (1.5-3/1000 live births). (1) People with CP have many disorders associated not only with the neuromuscular [...]

Introduction For the youth of our nation to have access to a quality education, it is imperative that prospective teachers participate in excellent preparation programs (Darling-Hammond, 1999; Tisher & Wideen, [...]

Patent Term Adjustment Updates On January 21, 2010, the US Patent and Trademark Office (USPTO) and the Department of Justice announced that they will not seek further court review of [...]

Development costs for new drugs are staggering. Some estimates put the cost in the range of about $900 Million to about 1.7 Billion Dollars for each new drug. This fact, [...]

Every patent issued by the US Patent and Trademark Office (USPTO) must include at least one claim. This is a requirement of the patent statute, 35 U.S.C. § 112, second [...]

End-of-year wrap-ups or early-in-the-year horoscopes have a value beyond just summarizing major events and trends. No matter what the subject, such features invite larger perspectives and a useful escape from [...]

Update on Inequitable Conduct I have previously addressed the Federal Circuit's April 2010 order granting en banc review of the inequitable conduct holding in Therasense v. Becton Dickenson & Co. [...]

Prometheus Labs. v. Mayo Update This case [Appeal No. 2008-1403] is one of the pending Federal Circuit cases that are questioning whether medical diagnostic and treatment methods are the proper [...]

Bilski Highlights On June 28, 2010, the Supreme Court handed down its decision in Bilski v. Kappos, affirming the Federal Circuit's decision rejecting the claims of the patent application, but [...]

Bits & Pieces--Update on Inequitable Conduct On April 26, 2010, the Court of Appeals for the Federal Circuit issued an order granting en banc review of the panel decision in [...]

Patent Term Adjustment Case Update On January 7, 2010, the US Court of Appeals for the Federal Circuit ruled in favor of Wyeth and Elan Pharma International Ltd. in their [...]

Patent cases are in the news lately--are big changes on the horizon? Will "business method patents" soon become a thing of the past? Will diagnostic method patents be impacted by [...]

I enjoy IP litigation. I even enjoy reading IP case decisions. I especially like bio/pharma IP cases--as I entered the IP field as an in-house patent practitioner at Merck back [...]

Pharmaceutical patent owners/ licensors and licensees-summer is becoming a memory but here are some "spring cleaning" tips for your consideration. Patent Term Adjustments Look at your recently issued and licensed [...]

Pharmaceutical patent owners/ licensors and licensees--summer is becoming a memory but, as a continuation of my last column, here are more "spring cleaning" tips for your consideration. Patent Term Adjustments [...]

Time for Spring Cleaning With the global economy down, now is a good time to take stock of your intellectual property portfolio and see what needs to be updated. Check [...]

Litigation involving Abbreviated New Drug Applications (ANDAs) appears to be increasing. Several interesting decisions have been rendered since my last column on this topic. These include: Sanofi Synthelabo v. Apotex--Federal [...]

This column is a continuation of last month's column regarding licensee due diligence--Who Owns the Patent--and the case of The University of Pittsburgh v. Hedrick, Civil Action No. 04-9014 (C.D. [...]

This column is intended to provide suggestions and case commentary that may assist the reader in dealing with licensing issues in technological areas where the Federal Food and Drug Administration [...]

Several months ago, Abbott Laboratories Inc. reached an agreement with the nation of Brazil that has been lauded as a salutary breakthrough in international relations by some and, by others, [...]

The following are two more cases involving Abbreviated New Drug Applications (ANDAs). Otsuka Pharmaceutical v. Barr Laboratories On December 5, 2008, Magistrate Hughes of the Federal District Court in New [...]

One of the first issues to be considered in a patent license situation, by both the licensee and the licensor is: Who owns the patent? The named inventors on a [...]